EVERolimus and LenvAtinib Versus Everolimus for Bone Sarcoma
EVERolimus and LenvAtinib Versus Everolimus for Bone Sarcoma
Not yet recruiting · NCT07619950 · Registry updated 2026-06-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| EVERolimus and LenvAtinib Versus Everolimus for Bone Sarcoma | Neoplasms by Site, bone disorder, musculoskeletal system disorder, neoplasm | Not yet recruiting | Phase 2 | 2026-06-02 | NCT07619950 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Yonsei University | 213 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||